Letter

Global access to vaccines

Poor nations are being lured into a debt trap

BMJ 2008; 336 doi: 10.1136/bmj.39563.529757.BE (Published 1 May 2008)
Cite this as: BMJ 2008;336:974.4

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Jacob M Puliyel, consultant paediatrician and head of department,
  2. Ashutosh Shrivastava, resident in paediatrics
  1. 1St Stephen’s Hospital, Tis Hazari, Delhi 110054, India
  1. puliyel{at}gmail.com

    With regard to access to papillomavirus vaccine (Gardasil),1 let us assume that the vaccine covers all strains causing cervical cancer. In India 21m girls would have to be vaccinated each year to avoid 260 000 deaths at a cost for the vaccine alone of $8400m. The programme would have to be sustained for over 20 years. Even if it prevented all cervical cancers, it would reduce by only 2% the 10.9m deaths caused by infectious …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    Read related article

    See previous polls

    BMJ most popular